ID: ALA3805765

Max Phase: Preclinical

Molecular Formula: C13H15N3O10

Molecular Weight: 373.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1

Standard InChI:  InChI=1S/C13H15N3O10/c17-4-8-10(18)11(19)9(13(21)26-8)14-12(20)5-1-6(15(22)23)3-7(2-5)16(24)25/h1-3,8-11,13,17-19,21H,4H2,(H,14,20)/t8-,9-,10-,11-,13?/m1/s1

Standard InChI Key:  GNVPUHGUOBDPSL-FGDGVPSKSA-N

Associated Targets(Human)

Hexokinase type I 266 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hexokinase type II 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 373.27Molecular Weight (Monoisotopic): 373.0757AlogP: -1.97#Rotatable Bonds: 5
Polar Surface Area: 205.53Molecular Species: NEUTRALHBA: 10HBD: 5
#RO5 Violations: 0HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.62CX Basic pKa: CX LogP: -1.49CX LogD: -1.49
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.28Np Likeness Score: 0.41

References

1. Lin H, Zeng J, Xie R, Schulz MJ, Tedesco R, Qu J, Erhard KF, Mack JF, Raha K, Rendina AR, Szewczuk LM, Kratz PM, Jurewicz AJ, Cecconie T, Martens S, McDevitt PJ, Martin JD, Chen SB, Jiang Y, Nickels L, Schwartz BJ, Smallwood A, Zhao B, Campobasso N, Qian Y, Briand J, Rominger CM, Oleykowski C, Hardwicke MA, Luengo JI..  (2016)  Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors.,  (3): [PMID:26985301] [10.1021/acsmedchemlett.5b00214]

Source